Why Bristol Myers Squibb Deserves a Place in Your Portfolio
Pharmaceutical stocks have been trading at a relative discount to the broader market recently, with the Vanguard Health Care Index Fund ETF (NYSEMKT: VHT) currently boasting a price-to-earnings ratio of about 14.45. That's cheap compared with, say, BlackRock's S&P 500 ETF (NYSEMKT: IVV) and its current P/E of 18.57.
One particularly notable sale-priced company in the sector is the pharmaceutical giant Bristol Myers Squibb (NYSE: BMY) The company has recently made acquisitions, increased dividends, and launched a new share buyback program, making 2021 a great time to buy in.
Image source: Getty Images.
Source Fool.com
